Kelly Molder

• Drive customer strategy and portfolio positioning for Global Media Solutions across protein and CGT markets in EMEA.
• Serve as senior scientific and commercial authority in strategic customer engagements, supporting high-value opportunities and long-term partnerships.
• Align R&D, Marketing, and Sales to convert technical platforms into differentiated value propositions and successful commercial launches.
• Represent Lonza at international conferences and strategic customer forums, engaging key industry stakeholders.

• Key contributor to the development and global launch of the TheraPRO® CHO Media System, ensuring portfolio readiness and successful market introduction.
• Provided data-driven recommendations to senior leadership, guiding R&D roadmaps and strategic investment decisions.

• Led DoE-based media optimization for fed-batch and perfusion processes across shake flasks, high-throughput ambr® systems, and 10 L STRs, supporting pilot-scale operations.
• Delivered technical recommendations to project teams to enhance process efficiency.

• Executed scale-up of fed-batch and perfusion processes across shake flasks, ambr® 15, ambr® 250, and 10 L STR systems.
• Implemented Chemspeed APD for automated media formulation and applied DoE-based approaches to improve process performance.

• Oversaw upstream GMP clinical manufacturing via iCELLis 500 bioreactors, integrating documentation and technology transfer processes.

• Optimised cell culture and viral vector production, advancing from ambr systems to 2 L STRs and undertaking bioanalytical assays.

• Outlined technical procedures and SOPs to optimise operational workflows.

Sir William Dunn School of Pathology

• Oversee recombinant protein production and purification processes involving bacterial, baculovirus, and mammalian expression systems.